Axel Bolte's background in venture financing served him well when it came time to set up shop at Inozyme Pharma Inc. But his deep ties to academia were even more important to the company's formation. Entrée to technology discovered at Yale University could enable Inozyme to offer a distinctly new approach to treat rare calcification disorders.